Bellerophon Therapeutics在盘前股价暴跌39%,因公司将被纳斯达克摘牌。查看全文
临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%,触及熔断。 网页链接
$柏勒罗丰治疗(BLPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001600132-20-000002 Act: 34 Size: 1 MB 网页链接
$柏勒罗丰治疗(BLPH)$ PRE 14A Other preliminary proxy statements Accession Number: 0001600132-19-000170 Act: 34 Size: 1 MB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 1.01, 7.01, 8.01, and 9.01 Accession Number: 0001600132-19-000166 Act: 34 Size: 1 MB 网页链接
$柏勒罗丰治疗(BLPH)$ 内部交易: 2019-11-25,Director,Wang Theodore T ,买入,7193普通股, $0.39
$柏勒罗丰治疗(BLPH)$ 内部交易: 2019-11-22,Director,Wang Theodore T ,买入,1050普通股, $0.37
$柏勒罗丰治疗(BLPH)$ 内部交易: 2019-11-21,Director,Wang Theodore T ,买入,200普通股, $0.37
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600132-19-000164 Size: 7 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600132-19-000158 Size: 4 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600132-19-000159 Size: 4 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600132-19-000160 Size: 4 KB 网页链接